Single Oral Dose Ibuprofen for Pain Relief in Fractional Curettage under Paracervical Block: A Double-Blind Randomized Controlled Trial
article
OA: green
CC0
AI-generated summary
A double-blind trial found that a single oral dose of ibuprofen before fractional curettage under paracervical block did not significantly reduce pain compared to placebo.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Objective To compare the analgesic efficacy of a single oral dose ibuprofen administered prior to fractional curettage under paracervical block with that of placebo in women undergoing fractional curettage. Design Double-blind, randomized controlled trial. Setting Gynaecological Out-patient, Department of Obstetrics and Gynaecology, Ramathibodi Hospital. Intervention The women were randomized to receive either 400 mg ibuprofen (n=70) or placebo(n=70) 30-60 minutes prior to fractional curettage. All women were curetted under paracervical block with 1% lidocaine. Main outcome measure The intensity of pain during and after the procedure measured by the visual analog score. Results The intensity of pain in ibuprofen group was not significant difference from the placebo group over the course of the procedure (P>0.05). There were no serious adverse effect from the procedure. Conclusion Pre-emptive single oral dose ibuprofen for fractional curettage under paracervical block did not relief pain during and after the procedure.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (1)
References (12)
- Prostaglandin synthetase inhibitors in the treatment of primary dysmenorrhea via openalex
- W175209175 via openalex
- W1984069070 via openalex
- W2009218297 via openalex
- W2009258166 via openalex
- W2024549342 via openalex
- W2039686704 via openalex
- W2065119432 via openalex
- W2087465742 via openalex
- W2092645644 via openalex
- W2412999443 via openalex
- W2574985073 via openalex
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK